Navigating Anthem (Elevance Health) Auvelity Prior Authorization

Successfully managing Anthem (Elevance Health) Auvelity prior authorization is critical for patient access to this novel antidepressant. Klivira provides the automation and intelligence required to navigate Anthem's specific requirements efficiently.

Auvelity, an oral N-methyl-D-aspartate (NMDA) receptor antagonist indicated for Major Depressive Disorder (MDD), frequently requires prior authorization (PA) across commercial, Medicare Advantage, and Medicaid managed care plans. For providers serving Anthem-licensed plan members, understanding the distinct submission pathways, policy access, and operational nuances of Elevance Health's ecosystem is key to minimizing delays and denials.

Auvelity Prior Authorization Submission Channels for Anthem Members

Anthem-licensed plans, operating under the Elevance Health corporate umbrella, utilize distinct channels for pharmacy and medical benefit prior authorizations. For Auvelity, primarily a pharmacy benefit drug, submissions typically route through CarelonRx, Elevance Health's in-house PBM. Providers can leverage established ePA partners or Anthem's direct portals.

Primary Submission Pathways for Auvelity with Anthem

**ePA via Surescripts or CoverMyMeds:** For retail pharmacy benefit Auvelity, prescribers can initiate electronic prior authorizations through these established ePA vendors, which integrate with CarelonRx.
**CarelonRx Provider Portal:** Direct submission through CarelonRx's dedicated provider PA system for pharmacy benefit medications.
**Availity Essentials:** While primarily for medical benefit PAs, Availity serves as Anthem's multi-payer provider workspace, offering member benefit lookup and access to Anthem's PA tools for other services.
**X12 278 Transactions:** Anthem supports X12 278 transactions via clearinghouses for medical benefit prior authorizations, though less common for oral pharmacy benefit drugs like Auvelity.

Accessing Anthem's Medical Policies and Clinical Guidelines for Auvelity

Anthem operating companies publish their medical-policy and clinical utilization management (UM) guideline libraries through provider sites, often accessed via Availity. Each state-licensed Anthem plan maintains its own policy index, aligned with the broader Elevance Health corporate criteria framework, including state-specific Medicaid and Medicare Advantage variants. Policies specify whether criteria are Anthem-developed, MCG-based, or NCCN-compendium-based.

Anthem's Prior Authorization Turnaround Times and CMS-0057-F Compliance

Prior authorization decision timeframes for Anthem-licensed plans vary. Commercial PA timeframes are governed by state insurance regulations. For Medicare Advantage, Medicaid managed care (including Wellpoint subsidiary), CHIP, and QHP-on-FFM lines, Anthem is an impacted payer under CMS-0057-F. This regulation mandates a 72-hour standard and 24-hour expedited decision timeframe, with phased compliance timelines. Klivira's automation helps track and manage these varying deadlines.

Common Denial Reasons and Appeal Pathways for Auvelity with Anthem

Denials for Auvelity PA with Anthem are typically returned via X12 277/835 transactions or Availity status updates. Common reasons include insufficient documentation, failure to meet medical necessity criteria, step therapy not completed, or non-formulary status. Appeals route through the Anthem operating-company appeals process, as documented in the provider manual, with peer-to-peer reviews available.

Typical Denial Categories for Auvelity with Anthem

**Medical Necessity / Insufficient Documentation:** Lack of comprehensive clinical notes supporting the diagnosis and prior treatment failures.
**Step Therapy Not Completed:** Failure to document trials and failures of preferred formulary alternatives.
**Non-Formulary Pharmacy Denials:** If Auvelity is not on the specific plan's formulary or requires a formulary exception.
**Quantity Limit Exceeded:** If the requested dosage or frequency exceeds the plan's established limits without clinical justification.

Frequently asked questions

How do I submit an Auvelity prior authorization to Anthem?

For Auvelity, primarily a pharmacy benefit drug, you will typically submit the prior authorization through ePA partners like Surescripts or CoverMyMeds, which integrate with CarelonRx. Alternatively, you can use the CarelonRx provider portal directly.

Where can I find Anthem's specific medical policies for Auvelity?

Anthem's medical policies and clinical guidelines are published on their provider websites, often accessible through Availity Essentials. It's crucial to consult the specific policy for the state and plan (commercial, Medicare Advantage, Medicaid) relevant to the member.

What are the typical turnaround times for Auvelity PA decisions from Anthem?

Turnaround times vary by plan type and state. Commercial plans adhere to state-mandated minimums. For Medicare Advantage and Medicaid plans, Anthem is subject to CMS-0057-F regulations, requiring decisions within 72 hours for standard requests and 24 hours for expedited requests.

What are common reasons for Auvelity PA denials from Anthem?

Common denial reasons include insufficient clinical documentation to support medical necessity, failure to complete required step therapy, or if Auvelity is considered non-formulary for the specific plan. Ensuring complete and accurate submissions is key.

What is the process for appealing an Auvelity PA denial from Anthem?

Appeals for Auvelity PA denials follow the standard Anthem operating-company appeals process, as outlined in the provider manual. This typically involves submitting a written appeal with additional clinical documentation, and peer-to-peer reviews are often available as part of this process.